-
-
-
-
-
-
-
Defence Therapeutics CEO outlines three strategic priorities in letter
-
-
-
-
-
-
-
Defence Therapeutics Appoints Dr. Amie Phinney as President and Chief Executive Officer
-
-
-
-
-
-
-
Defence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its Board of Directors
-
-
-
-
-
-
-
Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000
-
-
-
-
-
-
-
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
-
-
-
-
-
-
-
Defence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs
-
-
-
-
-
-
-
Defence Therapeutics Appoints Dr. Amie Phinney as Director
-
483,074 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


